Infusion-related reactions and premedication patterns in ublituximab-treated multiple sclerosis patients: a multicenter real-world study - Top-Institutions - MDSpire

Infusion-related reactions and premedication patterns in ublituximab-treated multiple sclerosis patients: a multicenter real-world study

  • By

  • Anas Z. Nourelden

  • Parker R. Scott

  • Sam I. Hooshmand

  • Izabela Mazur

  • Felicia Mada

  • Tesiley Ash

  • Nidhi Patel

  • Jacob Rube

  • Kalyan Yarraguntla

  • Carey Deluca

  • Patti Yager-Stone

  • Ryan Havens

  • Mitchell Wallin

  • Anza B. Memon

  • July 16, 2026

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Medical College of Wisconsin
    Medical College of Wisconsin

    Milwaukee, WI

    Key Differentiators

    • Neurology

  • #2

    Veterans Affairs MS centers
    Veterans Affairs MS centers

    Various, Various

    Key Differentiators

    • Neurology

  • #3

    University of Miami Hospital and Clinics, Sylvester Comprehensive Cancer Center
    University of Miami Hospital and Clinics, Sylvester Comprehensive Cancer Center

    Miami, FL

    Key Differentiators

    • Oncology
    • Neurology

  • #4

    Isala Hospital
    Isala Hospital

    Zwolle, Netherlands

    Key Differentiators

    • Pharmacy

  • #5

    H. Lee Moffitt Cancer Center and Research Institute
    H. Lee Moffitt Cancer Center and Research Institute

    Tampa, FL

    Key Differentiators

    • Oncology

Original Source(s)

Infusion-related reactions and premedication patterns in ublituximab-treated multiple sclerosis patients: a multicenter real-world study

  • by Anas Z. Nourelden, Parker R. Scott, Sam I. Hooshmand, Izabela Mazur, Felicia Mada, Tesiley Ash, Nidhi Patel, Jacob Rube, Kalyan Yarraguntla, Carey Deluca, Patti Yager-Stone, Ryan Havens, Mitchell Wallin, Anza B. Memon

  • July 16, 2026

Related Content

Epitranscriptomic regulation by m6A in immunity and autoimmune disorders: emerging mechanisms and clinical perspectives

Real-world comparison of anti-CD20 therapies: efficacy, infections, and immune profiles in a German cohort

Residual inflammation in the cerebrospinal fluid after short- and long-term natalizumab treatment in relapsing-remitting multiple sclerosis